Terbogrel
Terbogrel is a pharmacological agent that is classified as a thromboxane receptor antagonist and thromboxane synthase inhibitor. It is primarily used in the treatment of pulmonary arterial hypertension and other conditions that involve the overproduction of thromboxane.
Pharmacology[edit | edit source]
Terbogrel is a dual thromboxane receptor antagonist and thromboxane synthase inhibitor. This means that it works by blocking the action of thromboxane, a substance in the body that causes blood vessels to narrow and promotes clotting. By inhibiting the production and action of thromboxane, Terbogrel can help to widen blood vessels and prevent blood clots.
Clinical Uses[edit | edit source]
The primary use of Terbogrel is in the treatment of pulmonary arterial hypertension, a condition characterized by high blood pressure in the arteries that supply the lungs. By widening these arteries, Terbogrel can help to reduce blood pressure and improve symptoms.
In addition to pulmonary arterial hypertension, Terbogrel may also be used in the treatment of other conditions that involve the overproduction of thromboxane, such as coronary artery disease and peripheral artery disease.
Side Effects[edit | edit source]
Like all medications, Terbogrel can cause side effects. These may include nausea, vomiting, diarrhea, and abdominal pain. In rare cases, Terbogrel may also cause more serious side effects, such as bleeding or bruising.
See Also[edit | edit source]
- Thromboxane receptor antagonist
- Thromboxane synthase inhibitor
- Pulmonary arterial hypertension
- Coronary artery disease
- Peripheral artery disease
Terbogrel Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD